ArticleCancer2024
The 340B Program and oral specialty drugs for advanced prostate cancer.
Kassem S Faraj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleCancer2024
Kassem S Faraj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.